Search research articles
Contact Us
Filters
Showing results (671-680 of 942) with videos related to
Page
of 95
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy
J A de Lemos, E M Antman, D A Morrow, et al.
Journal of the American College of Cardiology
|
June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial
C Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.
Multiple Sclerosis and Related Disorders
|
March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGAD
Adnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
Journal of the American Heart Association
|
March 19, 2019
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists
Samuel B Brusca, Christopher Barnett, Brendan J Barnhart, et al.
Journal of the American Heart Association
|
March 21, 2025
Social Vulnerability and Long-Term Cardiovascular Outcomes After COVID-19 Hospitalization: An Analysis of the American Heart Association COVID-19 Registry Linked With Medicare Claims Data
Reza Fakhraei, Yang Song, Dhruv S Kazi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 15, 2018
Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner
Jiwon Oh, Marie-Sarah Gagné-Brosseau, Melanie Guenette, et al.
American Heart Journal
|
September 11, 2021
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial
Matthew A Cavender, Michelle L O'Donoghue, Antonio Abbate, et al.
Circulation
|
February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial
Marc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Journal of Pediatric Surgery
|
October 29, 2017
Severe neurodevelopmental disability and healthcare needs among survivors of medical and surgical necrotizing enterocolitis: A prospective cohort study
Brenna S Fullerton, Charles R Hong, Cristine S Velazco, et al.
Plos Pathogens
|
October 17, 2012
De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans
Carl A Morrow, Eugene Valkov, Anna Stamp, et al.
Page
of 95
Search research articles
Search
Showing results (671-680 of 942) with videos related to
Sort By:
Page
of 95
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 6, 2000
Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy
J A de Lemos, E M Antman, D A Morrow, et al.
Journal of the American College of Cardiology
|
June 15, 2007
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial
C Michael Gibson, Sabina A Murphy, Gilles Montalescot, et al.
Multiple Sclerosis and Related Disorders
|
March 29, 2025
Comparison of vision-related quality of life in NMOSD and MOGAD
Adnan A Gassan, Andrea Konig, Rosane Nisenbaum, et al.
Journal of the American Heart Association
|
March 19, 2019
Role of Critical Care Medicine Training in the Cardiovascular Intensive Care Unit: Survey Responses From Dual Certified Critical Care Cardiologists
Samuel B Brusca, Christopher Barnett, Brendan J Barnhart, et al.
Journal of the American Heart Association
|
March 21, 2025
Social Vulnerability and Long-Term Cardiovascular Outcomes After COVID-19 Hospitalization: An Analysis of the American Heart Association COVID-19 Registry Linked With Medicare Claims Data
Reza Fakhraei, Yang Song, Dhruv S Kazi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 15, 2018
Toward a Shared-Care Model of Relapsing-Remitting Multiple Sclerosis: Role of the Primary Care Practitioner
Jiwon Oh, Marie-Sarah Gagné-Brosseau, Melanie Guenette, et al.
American Heart Journal
|
September 11, 2021
Inhibition of p38 MAP kinase in patients with ST-elevation myocardial infarction - findings from the LATITUDE-TIMI 60 trial
Matthew A Cavender, Michelle L O'Donoghue, Antonio Abbate, et al.
Circulation
|
February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial
Marc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Journal of Pediatric Surgery
|
October 29, 2017
Severe neurodevelopmental disability and healthcare needs among survivors of medical and surgical necrotizing enterocolitis: A prospective cohort study
Brenna S Fullerton, Charles R Hong, Cristine S Velazco, et al.
Plos Pathogens
|
October 17, 2012
De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans
Carl A Morrow, Eugene Valkov, Anna Stamp, et al.
Page
of 95